{
  "ticker": "TTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963006",
  "id": "02963006",
  "pages": 18,
  "price_sensitive": false,
  "date": "20250627",
  "time": "1454",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l5z3n1mc8wg2.pdf",
  "summary": "Based on the provided ASX Listing Information Form and Checklist for Tetratherix Limited, here is the concise extraction of material information relevant for trading or capital markets decisions:\n\n**IPO/Listing Application**  \n- **Entity Name**: Tetratherix Limited (ACN 607 771 077)  \n- **Main Business Activity**: Development, manufacture, and sale of patented biomaterials (Australia-based).  \n- **Capital Structure**:  \n  - Free float at listing will be \u226520% (per Listing Rule 1.1 Condition 7).  \n  - Issue price of securities \u226520 cents (per Listing Rule 2.1 Condition 2).  \n- **Key Dates**:  \n  - Annual financial year end: 30 June.  \n  - Annual meeting month: November.  \n- **Corporate Governance**: Complies with ASX Corporate Governance Council recommendations (audit and remuneration committees disclosed in Prospectus section 5.9).  \n- **Use of Proceeds**: Detailed in Prospectus section 6.4 (funding business objectives).  \n\n**No material information identified** for trading halts, capital raisings, or financial results. Document primarily outlines regulatory compliance for listing admission.  \n\n*Note: Omitted non-material operational/legal details per instructions.*",
  "usage": {
    "prompt_tokens": 12469,
    "completion_tokens": 259,
    "total_tokens": 12728,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-27T05:41:42.857710"
}